Skip to main content
Year archive

Leadway Technology Investment Group Limited — 2019 filings

All 68 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2019, sourced directly from the official regulator.

68 Filings
2019 Period
2019 filings (68)
Filing Released Lang
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-12-20 English
CHANGES IN DIRECTORSHIP
Board/Management Information
2019-12-20 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2019-12-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2019
Share Issue/Capital Change
2019-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019
Capital/Financing Update
2019-12-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
Regulatory Filings
2019-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2019
Share Issue/Capital Change
2019-11-01 English
Voluntary Announcement - Proposed Change of Shareholding Structure of Intermediate Controlling Shareholder of the Company
Regulatory Filings
2019-11-01 English
Unaudited Financial Results for the nine months ended 30 September 2019 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report 9M 2019
2019-10-25 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2019
Share Issue/Capital Change
2019-10-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
Regulatory Filings
2019-10-02 English
2019 Interim Report
Interim / Quarterly Report H1 2019
2019-09-19 English
Interim Report 2019
Interim / Quarterly Report H1 2019
2019-09-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2019
Regulatory Filings
2019-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
Share Issue/Capital Change
2019-09-02 English
Announcement of Interim Results for the six months ended 30 June 2019
Interim / Quarterly Report H1 2019
2019-08-29 English
List of Directors and their Roles and Functions
Board/Management Information
2019-08-29 English
Change of Directors and Change of Authorised Representative
Board/Management Information
2019-08-29 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2019
Interim / Quarterly Report H1 2019
2019-08-27 English
INSIDE INFORMATION PLEDGE OF SHARES BY THE CONTROLLING SHAREHOLDER
Major Shareholding Notification
2019-08-27 English
Unaudited Financial Results for the six months ended 30 June 2019 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report H1 2019
2019-08-23 English
Date of Board Meeting
Regulatory Filings
2019-08-12 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-08-08 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-08-05 English
CHANGES IN DIRECTORSHIP AND CHIEF EXECUTIVE OFFICER
Board/Management Information
2019-08-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2019
Regulatory Filings
2019-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2019
Share Issue/Capital Change
2019-08-01 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-07-17 English
CHANGES IN EXECUTIVE DIRECTORS
Board/Management Information
2019-07-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2019
Share Issue/Capital Change
2019-07-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2019
Share Issue/Capital Change
2019-07-02 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-06-17 English
CHANGES IN EXECUTIVE DIRECTORS
Board/Management Information
2019-06-17 English
Poll Results of the Annual General Meeting held on 5 June 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2019
Capital/Financing Update
2019-06-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2019
Share Issue/Capital Change
2019-06-03 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-05-30 English
RETIREMENT OF EXECUTIVE DIRECTOR
Board/Management Information
2019-05-30 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2019
Declaration of Voting Results & Voting Rights Announcements
2019-05-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2019
Capital/Financing Update
2019-05-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
Regulatory Filings
2019-05-02 English
Notice of Annual General Meeting
AGM Information
2019-04-29 English
Form of Proxy for Annual General Meeting to be held on 5 June 2019
Proxy Solicitation & Information Statement
2019-04-26 English
General Mandates to Issue Shares and to Buy Back Shares, Re-election of Directors and Notice of Annual General Meeting
AGM Information
2019-04-26 English
Annual Report 2018
Annual Report FY 2018
2019-04-26 English
Unaudited Financial Results for the three months ended 31 March 2019 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report Q1 2019
2019-04-24 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof)
AGM Information
2019-04-17 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-17 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-17 English
Annual Report 2018
Annual Report FY 2018
2019-04-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2019
Share Issue/Capital Change
2019-04-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
Share Issue/Capital Change
2019-04-01 English
Announcement of Final Results for the year ended 31 December 2018
Annual Report FY 2018
2019-03-28 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report FY 2018
2019-03-27 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Board/Management Information
2019-03-27 English
Audited Financial Results for the year ended 31 December 2018 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Annual Report FY 2018
2019-03-25 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-03-15 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2019-03-15 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE OF BOARD COMMITTEE AND COMPLIANCE WITH RULES 3.10(1), 3.10A AND 3.21 OF THE LISTING RULES
Board/Management Information
2019-03-15 English
Date of Board Meeting
Regulatory Filings
2019-03-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2019
Share Issue/Capital Change
2019-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2019
Regulatory Filings
2019-03-01 English
Overseas Regulatory Announcement
Earnings Release FY 2018
2019-02-28 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2019
Share Issue/Capital Change
2019-02-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2019
Share Issue/Capital Change
2019-02-01 English
Major Transaction - Merger of Tsinlien Electric and TEDA Power
Proxy Solicitation & Information Statement
2019-01-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2018
Share Issue/Capital Change
2019-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2018
Share Issue/Capital Change
2019-01-02 English